Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02106481 · ClinicalTrials.gov registry record · NA

Comparing Femoral Nerve Catheters to Single Shot Femoral Nerve Blocks for Total Knee Replacement Surgery

A NA study, sponsored by Eastern Maine Medical Center.

Completed
Registry status
NA
Development phase
99
Enrollment target

NCT02106481: Completed NA study, sponsored by Eastern Maine Medical Center.

NCT02106481 is a NA study that has completed, run by Eastern Maine Medical Center. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02106481, a NA study, has completed, sponsored by Eastern Maine Medical Center.

COMPLETED
Registry status
NA
Development phase
99 participants
Enrollment target

Study Summary

The purpose of this study is to compare two methods of pain control used during total knee joint replacement surgery. The pain medication that will be used for this study is not experimental. The investigators will compare the single shot femoral nerve block (SSFNB) and Femoral Nerve Block (FNB) plus continuous femoral nerve catheter (CFNC) to determine which method gives patients better pain control, increasing the capability to participate in physical therapy and decreasing the consumption of other pain medication. With either the single shot or the catheter the local numbing medication called ropivacaine will be used.

Primary Outcome

Pain Analog Scale- 0-10 were 10 is the worst possible pain and 0 is no pain at all.

Interventions

  • DRUG Femoral Nerve Catheters
  • DRUG Single Shot Femoral Nerve Blocks

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2014-04
Est. Completion 2015-12
Phase NA
Eastern Maine Medical Center

3 total trials

What the finished NCT02106481 record still lists

NCT02106481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Femoral Nerve Catheters is the first listed.

NCT02106481 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02106481 about?

NCT02106481 is a clinical study titled "Comparing Femoral Nerve Catheters to Single Shot Femoral Nerve Blocks for Total Knee Replacement Surgery". The purpose of this study is to compare two methods of pain control used during total knee joint replacement surgery. The pain medication that will be used for this study is not experimental. The investigators will compare the single shot femoral nerve block (SSFNB) and Femoral Nerve Block (FNB) pl...

What is the current status of trial NCT02106481?

This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2014-04. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02106481?

The interventions under investigation include: Femoral Nerve Catheters (DRUG), Single Shot Femoral Nerve Blocks (DRUG).

Who is sponsoring clinical trial NCT02106481?

This trial is sponsored by Eastern Maine Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02106481's enrollment target sits among peer trials

99 920th of 2000 higher than 1,079 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03965234 · 99 participants · Phase 1

    Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

  • NCT04022616 · 99 participants

    Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

  • NCT04042844 · 99 participants · Phase 2

    A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

  • NCT04143724 · 99 participants · Phase 2

    Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02106481, the US trial registry maintained by the National Library of Medicine. NCT02106481 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.